Vaccine,Dose,Geography Type,Geography,Birth Year,Age,Estimate (%),95% CI (%),Sample Size
Combined 7 Series,,HHS Regions/National,United States,2011,24 Months,67.7,66.1 to 69.3,14513
Combined 7 Series,,HHS Regions/National,United States,2011,35 Months,74.4,72.6 to 76.1,14513
DTaP,³1 Dose,HHS Regions/National,United States,2011,3 Months,88.1,86.9 to 89.2,14513
DTaP,³2 Doses,HHS Regions/National,United States,2011,5 Months,78.9,77.3 to 80.4,14513
DTaP,³3 Doses,HHS Regions/National,United States,2011,13 Months,89.2,88.0 to 90.3,14513
DTaP,³3 Doses,HHS Regions/National,United States,2011,19 Months,92.5,91.3 to 93.5,14513
DTaP,³3 Doses,HHS Regions/National,United States,2011,24 Months,93.6,92.6 to 94.5,14513
DTaP,³3 Doses,HHS Regions/National,United States,2011,35 Months,95,93.9 to 95.9,14513
DTaP,³3 Doses,HHS Regions/National,United States,2011,7 Months,70.3,68.7 to 72.0,14513
DTaP,³4 Doses,HHS Regions/National,United States,2011,19 Months,69.2,67.6 to 70.7,14513
DTaP,³4 Doses,HHS Regions/National,United States,2011,24 Months,80.7,79.3 to 82.0,14513
DTaP,³4 Doses,HHS Regions/National,United States,2011,35 Months,87.6,86.1 to 89.1,14513
Hep A,³1 Dose,HHS Regions/National,United States,2011,19 Months,75,73.0 to 76.9,14513
Hep A,³1 Dose,HHS Regions/National,United States,2011,24 Months,80.6,79.2 to 81.9,14513
Hep A,³1 Dose,HHS Regions/National,United States,2011,35 Months,87.4,86.0 to 88.8,14513
Hep A,³2 Doses,HHS Regions/National,United States,2011,19 Months,20.2,19.0 to 21.4,14513
Hep A,³2 Doses,HHS Regions/National,United States,2011,24 Months,39.9,38.1 to 41.6,14513
Hep A,³2 Doses,HHS Regions/National,United States,2011,35 Months,71.1,69.1 to 73.0,14513
Hep B,³1 Dose,HHS Regions/National,United States,2011,3 Months,93.6,92.8 to 94.4,14513
Hep B,"³1 Dose, 1 Day",HHS Regions/National,United States,2011,0-1 Days,64.4,62.2 to 66.6,14513
Hep B,"³1 Dose, 2 Day",HHS Regions/National,United States,2011,0-2 Days,71.5,69.4 to 73.5,14513
Hep B,"³1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2011,0-3 Days,73.2,71.7 to 74.7,14513
Hep B,³2 Doses,HHS Regions/National,United States,2011,13 Months,93.3,92.5 to 94.1,14513
Hep B,³2 Doses,HHS Regions/National,United States,2011,5 Months,84.9,83.8 to 86.0,14513
Hep B,³2 Doses,HHS Regions/National,United States,2011,7 Months,89.6,88.6 to 90.5,14513
Hep B,³3 Doses,HHS Regions/National,United States,2011,13 Months,84,82.8 to 85.1,14513
Hep B,³3 Doses,HHS Regions/National,United States,2011,19 Months,88.3,87.3 to 89.3,14513
Hep B,³3 Doses,HHS Regions/National,United States,2011,24 Months,89.8,88.7 to 90.8,14513
Hep B,³3 Doses,HHS Regions/National,United States,2011,35 Months,91.2,90.1 to 92.3,14513
Hep B,³3 Doses,HHS Regions/National,United States,2011,7 Months,52.9,51.1 to 54.8,14513
Hib,³1 Dose,HHS Regions/National,United States,2011,3 Months,87.1,85.8 to 88.2,14513
Hib,³2 Doses,HHS Regions/National,United States,2011,13 Months,93.3,92.4 to 94.2,14513
Hib,³2 Doses,HHS Regions/National,United States,2011,5 Months,77.6,76.1 to 79.1,14513
Hib,³2 Doses,HHS Regions/National,United States,2011,7 Months,88.9,87.8 to 89.9,14513
Hib,³3 Doses,HHS Regions/National,United States,2011,13 Months,83.5,82.1 to 84.8,14513
Hib,³3 Doses,HHS Regions/National,United States,2011,19 Months,90.8,89.7 to 91.9,14513
Hib,³3 Doses,HHS Regions/National,United States,2011,24 Months,92.1,91.1 to 93.1,14513
Hib,³3 Doses,HHS Regions/National,United States,2011,35 Months,93.5,92.4 to 94.4,14513
Hib,³3 Doses,HHS Regions/National,United States,2011,7 Months,63,61.2 to 64.9,14513
Hib,Full Series,HHS Regions/National,United States,2011,19 Months,72.6,71.3 to 73.9,14513
Hib,Full Series,HHS Regions/National,United States,2011,24 Months,79.9,78.5 to 81.3,14513
Hib,Full Series,HHS Regions/National,United States,2011,35 Months,84.8,83.2 to 86.3,14513
Hib,Primary Series,HHS Regions/National,United States,2011,13 Months,88.7,87.5 to 89.7,14513
Hib,Primary Series,HHS Regions/National,United States,2011,19 Months,92.1,91.0 to 93.1,14513
Hib,Primary Series,HHS Regions/National,United States,2011,24 Months,92.8,91.8 to 93.8,14513
Hib,Primary Series,HHS Regions/National,United States,2011,35 Months,93.7,92.7 to 94.6,14513
Hib,Primary Series,HHS Regions/National,United States,2011,7 Months,70.3,68.7 to 71.8,14513
Influenza,,HHS Regions/National,United States,2011,24 Months,52.6,50.9 to 54.3,14513
Influenza,,HHS Regions/National,United States,2011,35 Months,52.6,50.9 to 54.3,14513
MMR,³1 Dose,HHS Regions/National,United States,2011,13 Months,54,51.8 to 56.2,14513
MMR,³1 Dose,HHS Regions/National,United States,2011,19 Months,86.8,85.6 to 88.0,14513
MMR,³1 Dose,HHS Regions/National,United States,2011,24 Months,90.1,89.0 to 91.2,14513
MMR,³1 Dose,HHS Regions/National,United States,2011,35 Months,93.2,91.9 to 94.3,14513
PCV,³1 Dose,HHS Regions/National,United States,2011,3 Months,84.6,83.3 to 85.9,14513
PCV,³2 Doses,HHS Regions/National,United States,2011,5 Months,74.6,73.0 to 76.2,14513
PCV,³3 Doses,HHS Regions/National,United States,2011,13 Months,86.9,85.6 to 88.0,14513
PCV,³3 Doses,HHS Regions/National,United States,2011,19 Months,90.4,89.2 to 91.4,14513
PCV,³3 Doses,HHS Regions/National,United States,2011,24 Months,91.6,90.4 to 92.6,14513
PCV,³3 Doses,HHS Regions/National,United States,2011,35 Months,92.6,91.6 to 93.7,14513
PCV,³3 Doses,HHS Regions/National,United States,2011,7 Months,64.9,63.2 to 66.4,14513
PCV,³4 Doses,HHS Regions/National,United States,2011,19 Months,75.9,74.5 to 77.2,14513
PCV,³4 Doses,HHS Regions/National,United States,2011,24 Months,80.8,79.4 to 82.2,14513
PCV,³4 Doses,HHS Regions/National,United States,2011,35 Months,84.6,83.1 to 86.1,14513
Polio,³1 Dose,HHS Regions/National,United States,2011,3 Months,86.9,85.7 to 88.1,14513
Polio,³2 Doses,HHS Regions/National,United States,2011,13 Months,93.5,92.4 to 94.4,14513
Polio,³2 Doses,HHS Regions/National,United States,2011,5 Months,77.5,75.9 to 79.1,14513
Polio,³2 Doses,HHS Regions/National,United States,2011,7 Months,88.9,87.8 to 89.9,14513
Polio,³3 Doses,HHS Regions/National,United States,2011,19 Months,90.4,89.2 to 91.5,14513
Polio,³3 Doses,HHS Regions/National,United States,2011,24 Months,92,90.9 to 93.0,14513
Polio,³3 Doses,HHS Regions/National,United States,2011,35 Months,93.8,92.7 to 94.8,14513
Rotavirus,,HHS Regions/National,United States,2011,8 Months,70.8,69.2 to 72.3,14513
Varicella,³1 Dose,HHS Regions/National,United States,2011,13 Months,56.2,54.0 to 58.3,14513
Varicella,³1 Dose,HHS Regions/National,United States,2011,19 Months,86.5,85.1 to 87.7,14513
Varicella,³1 Dose,HHS Regions/National,United States,2011,24 Months,89.2,88.1 to 90.3,14513
Varicella,³1 Dose,HHS Regions/National,United States,2011,35 Months,92.7,91.5 to 93.8,14513
Combined 7 Series,,HHS Regions/National,United States,2012,24 Months,69,67.4 to 70.5,15039
Combined 7 Series,,HHS Regions/National,United States,2012,35 Months,75.9,74.3 to 77.5,15039
DTaP,³1 Dose,HHS Regions/National,United States,2012,3 Months,87.4,86.3 to 88.4,15039
DTaP,³2 Doses,HHS Regions/National,United States,2012,5 Months,78,76.8 to 79.0,15039
DTaP,³3 Doses,HHS Regions/National,United States,2012,13 Months,90,89.1 to 90.8,15039
DTaP,³3 Doses,HHS Regions/National,United States,2012,19 Months,93.2,92.4 to 94.0,15039
DTaP,³3 Doses,HHS Regions/National,United States,2012,24 Months,94.2,93.4 to 94.8,15039
DTaP,³3 Doses,HHS Regions/National,United States,2012,35 Months,95.3,94.6 to 95.9,15039
DTaP,³3 Doses,HHS Regions/National,United States,2012,7 Months,68.3,66.7 to 69.8,15039
DTaP,³4 Doses,HHS Regions/National,United States,2012,19 Months,69,67.5 to 70.5,15039
DTaP,³4 Doses,HHS Regions/National,United States,2012,24 Months,81.4,80.1 to 82.7,15039
DTaP,³4 Doses,HHS Regions/National,United States,2012,35 Months,88.6,87.3 to 89.8,15039
Hep A,³1 Dose,HHS Regions/National,United States,2012,19 Months,76.8,75.3 to 78.2,15039
Hep A,³1 Dose,HHS Regions/National,United States,2012,24 Months,82.8,81.6 to 84.1,15039
Hep A,³1 Dose,HHS Regions/National,United States,2012,35 Months,88.4,87.1 to 89.7,15039
Hep A,³2 Doses,HHS Regions/National,United States,2012,19 Months,21.2,19.9 to 22.5,15039
Hep A,³2 Doses,HHS Regions/National,United States,2012,24 Months,39.9,38.3 to 41.6,15039
Hep A,³2 Doses,HHS Regions/National,United States,2012,35 Months,72.8,70.8 to 74.8,15039
Hep B,³1 Dose,HHS Regions/National,United States,2012,3 Months,93.8,92.8 to 94.7,15039
Hep B,"³1 Dose, 1 Day",HHS Regions/National,United States,2012,0-1 Days,64.6,62.1 to 66.9,15039
Hep B,"³1 Dose, 2 Day",HHS Regions/National,United States,2012,0-2 Days,71.2,68.9 to 73.4,15039
Hep B,"³1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2012,0-3 Days,72.8,71.3 to 74.2,15039
Hep B,³2 Doses,HHS Regions/National,United States,2012,13 Months,94.1,93.4 to 94.7,15039
Hep B,³2 Doses,HHS Regions/National,United States,2012,5 Months,86.4,85.3 to 87.4,15039
Hep B,³2 Doses,HHS Regions/National,United States,2012,7 Months,91.2,90.4 to 92.0,15039
Hep B,³3 Doses,HHS Regions/National,United States,2012,13 Months,87.4,86.2 to 88.4,15039
Hep B,³3 Doses,HHS Regions/National,United States,2012,19 Months,90.4,89.4 to 91.3,15039
Hep B,³3 Doses,HHS Regions/National,United States,2012,24 Months,91.4,90.6 to 92.2,15039
Hep B,³3 Doses,HHS Regions/National,United States,2012,35 Months,93.1,92.2 to 93.9,15039
Hep B,³3 Doses,HHS Regions/National,United States,2012,7 Months,59.2,57.2 to 61.1,15039
Hib,³1 Dose,HHS Regions/National,United States,2012,3 Months,86.1,85.1 to 87.1,15039
Hib,³2 Doses,HHS Regions/National,United States,2012,13 Months,94.1,93.4 to 94.7,15039
Hib,³2 Doses,HHS Regions/National,United States,2012,5 Months,76.3,75.2 to 77.4,15039
Hib,³2 Doses,HHS Regions/National,United States,2012,7 Months,89.6,88.6 to 90.5,15039
Hib,³3 Doses,HHS Regions/National,United States,2012,13 Months,80.9,79.3 to 82.4,15039
Hib,³3 Doses,HHS Regions/National,United States,2012,19 Months,90.7,89.7 to 91.6,15039
Hib,³3 Doses,HHS Regions/National,United States,2012,24 Months,92.3,91.5 to 93.0,15039
Hib,³3 Doses,HHS Regions/National,United States,2012,35 Months,93.7,92.9 to 94.5,15039
Hib,³3 Doses,HHS Regions/National,United States,2012,7 Months,57.5,55.7 to 59.3,15039
Hib,Full Series,HHS Regions/National,United States,2012,19 Months,73.1,71.8 to 74.4,15039
Hib,Full Series,HHS Regions/National,United States,2012,24 Months,80.2,78.8 to 81.5,15039
Hib,Full Series,HHS Regions/National,United States,2012,35 Months,84.7,83.2 to 86.0,15039
Hib,Primary Series,HHS Regions/National,United States,2012,13 Months,88.5,87.5 to 89.4,15039
Hib,Primary Series,HHS Regions/National,United States,2012,19 Months,92.4,91.5 to 93.1,15039
Hib,Primary Series,HHS Regions/National,United States,2012,24 Months,93.6,92.8 to 94.2,15039
Hib,Primary Series,HHS Regions/National,United States,2012,35 Months,94.4,93.6 to 95.0,15039
Hib,Primary Series,HHS Regions/National,United States,2012,7 Months,68.7,67.1 to 70.3,15039
Influenza,,HHS Regions/National,United States,2012,24 Months,54.1,52.5 to 55.7,15038
Influenza,,HHS Regions/National,United States,2012,35 Months,54.1,52.5 to 55.7,15038
MMR,³1 Dose,HHS Regions/National,United States,2012,13 Months,53.8,51.8 to 55.7,15039
MMR,³1 Dose,HHS Regions/National,United States,2012,19 Months,86.8,85.8 to 87.7,15039
MMR,³1 Dose,HHS Regions/National,United States,2012,24 Months,90.6,89.7 to 91.4,15039
MMR,³1 Dose,HHS Regions/National,United States,2012,35 Months,94.1,93.3 to 94.8,15039
PCV,³1 Dose,HHS Regions/National,United States,2012,3 Months,84.1,83.0 to 85.1,15039
PCV,³2 Doses,HHS Regions/National,United States,2012,5 Months,74.3,73.0 to 75.6,15039
PCV,³3 Doses,HHS Regions/National,United States,2012,13 Months,88,87.0 to 88.9,15039
PCV,³3 Doses,HHS Regions/National,United States,2012,19 Months,91.5,90.6 to 92.3,15039
PCV,³3 Doses,HHS Regions/National,United States,2012,24 Months,92.6,91.6 to 93.5,15039
PCV,³3 Doses,HHS Regions/National,United States,2012,35 Months,93.5,92.5 to 94.4,15039
PCV,³3 Doses,HHS Regions/National,United States,2012,7 Months,64.5,62.8 to 66.1,15039
PCV,³4 Doses,HHS Regions/National,United States,2012,19 Months,77.5,76.1 to 78.9,15039
PCV,³4 Doses,HHS Regions/National,United States,2012,24 Months,82.4,81.1 to 83.6,15039
PCV,³4 Doses,HHS Regions/National,United States,2012,35 Months,85.4,84.1 to 86.7,15039
Polio,³1 Dose,HHS Regions/National,United States,2012,3 Months,86.3,85.2 to 87.4,15039
Polio,³2 Doses,HHS Regions/National,United States,2012,13 Months,94.2,93.5 to 94.8,15039
Polio,³2 Doses,HHS Regions/National,United States,2012,5 Months,76.4,75.3 to 77.5,15039
Polio,³2 Doses,HHS Regions/National,United States,2012,7 Months,89.6,88.7 to 90.5,15039
Polio,³3 Doses,HHS Regions/National,United States,2012,19 Months,91.5,90.5 to 92.4,15039
Polio,³3 Doses,HHS Regions/National,United States,2012,24 Months,93,92.3 to 93.7,15039
Polio,³3 Doses,HHS Regions/National,United States,2012,35 Months,94.3,93.6 to 95.0,15039
Rotavirus,,HHS Regions/National,United States,2012,8 Months,71.3,69.7 to 72.7,15039
Varicella,³1 Dose,HHS Regions/National,United States,2012,13 Months,56.7,55.2 to 58.2,15039
Varicella,³1 Dose,HHS Regions/National,United States,2012,19 Months,86.3,85.1 to 87.4,15039
Varicella,³1 Dose,HHS Regions/National,United States,2012,24 Months,90.2,89.3 to 91.0,15039
Varicella,³1 Dose,HHS Regions/National,United States,2012,35 Months,94,93.2 to 94.7,15039
Combined 7 Series,,HHS Regions/National,United States,2013,24 Months,68.3,66.8 to 69.7,14872
Combined 7 Series,,HHS Regions/National,United States,2013,35 Months,74.8,73.3 to 76.3,14872
DTaP,³1 Dose,HHS Regions/National,United States,2013,3 Months,87.6,86.6 to 88.5,14872
DTaP,³2 Doses,HHS Regions/National,United States,2013,5 Months,77.2,75.7 to 78.6,14872
DTaP,³3 Doses,HHS Regions/National,United States,2013,13 Months,90.4,89.4 to 91.3,14872
DTaP,³3 Doses,HHS Regions/National,United States,2013,19 Months,93.2,92.5 to 93.8,14872
DTaP,³3 Doses,HHS Regions/National,United States,2013,24 Months,94.2,93.5 to 94.9,14872
DTaP,³3 Doses,HHS Regions/National,United States,2013,35 Months,95.6,94.9 to 96.2,14872
DTaP,³3 Doses,HHS Regions/National,United States,2013,7 Months,68.2,66.8 to 69.5,14872
DTaP,³4 Doses,HHS Regions/National,United States,2013,19 Months,70.6,69.2 to 71.9,14872
DTaP,³4 Doses,HHS Regions/National,United States,2013,24 Months,81.2,79.9 to 82.5,14872
DTaP,³4 Doses,HHS Regions/National,United States,2013,35 Months,88.2,87.0 to 89.3,14872
Hep A,³1 Dose,HHS Regions/National,United States,2013,19 Months,78.5,77.2 to 79.9,14872
Hep A,³1 Dose,HHS Regions/National,United States,2013,24 Months,83.1,81.9 to 84.3,14872
Hep A,³1 Dose,HHS Regions/National,United States,2013,35 Months,88.5,87.4 to 89.6,14872
Hep A,³2 Doses,HHS Regions/National,United States,2013,19 Months,24.1,22.4 to 25.9,14872
Hep A,³2 Doses,HHS Regions/National,United States,2013,24 Months,42.4,40.8 to 44.0,14872
Hep A,³2 Doses,HHS Regions/National,United States,2013,35 Months,74.5,72.7 to 76.2,14872
Hep B,³1 Dose,HHS Regions/National,United States,2013,3 Months,94.5,94.0 to 95.0,14872
Hep B,"³1 Dose, 1 Day",HHS Regions/National,United States,2013,0-1 Days,64.2,62.1 to 66.3,14872
Hep B,"³1 Dose, 2 Day",HHS Regions/National,United States,2013,0-2 Days,70.9,69.1 to 72.7,14872
Hep B,"³1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2013,0-3 Days,72.6,71.2 to 74.0,14872
Hep B,³2 Doses,HHS Regions/National,United States,2013,13 Months,94.4,93.8 to 95.0,14872
Hep B,³2 Doses,HHS Regions/National,United States,2013,5 Months,86.3,85.2 to 87.4,14872
Hep B,³2 Doses,HHS Regions/National,United States,2013,7 Months,91.1,90.3 to 91.9,14872
Hep B,³3 Doses,HHS Regions/National,United States,2013,13 Months,87.8,86.9 to 88.7,14872
Hep B,³3 Doses,HHS Regions/National,United States,2013,19 Months,90.8,90.0 to 91.5,14872
Hep B,³3 Doses,HHS Regions/National,United States,2013,24 Months,91.6,90.7 to 92.4,14872
Hep B,³3 Doses,HHS Regions/National,United States,2013,35 Months,93,92.2 to 93.8,14872
Hep B,³3 Doses,HHS Regions/National,United States,2013,7 Months,61.2,59.1 to 63.1,14872
Hib,³1 Dose,HHS Regions/National,United States,2013,3 Months,85.5,84.4 to 86.5,14872
Hib,³2 Doses,HHS Regions/National,United States,2013,13 Months,94.1,93.5 to 94.7,14872
Hib,³2 Doses,HHS Regions/National,United States,2013,5 Months,74.8,73.2 to 76.4,14872
Hib,³2 Doses,HHS Regions/National,United States,2013,7 Months,88.9,87.9 to 89.8,14872
Hib,³3 Doses,HHS Regions/National,United States,2013,13 Months,78.4,76.4 to 80.2,14872
Hib,³3 Doses,HHS Regions/National,United States,2013,19 Months,90.7,89.9 to 91.5,14872
Hib,³3 Doses,HHS Regions/National,United States,2013,24 Months,92.4,91.6 to 93.1,14872
Hib,³3 Doses,HHS Regions/National,United States,2013,35 Months,94.1,93.3 to 94.8,14872
Hib,³3 Doses,HHS Regions/National,United States,2013,7 Months,54.5,52.4 to 56.6,14872
Hib,Full Series,HHS Regions/National,United States,2013,19 Months,74.7,73.5 to 76.0,14872
Hib,Full Series,HHS Regions/National,United States,2013,24 Months,80.8,79.6 to 82.1,14872
Hib,Full Series,HHS Regions/National,United States,2013,35 Months,85,83.7 to 86.1,14872
Hib,Primary Series,HHS Regions/National,United States,2013,13 Months,88.3,87.2 to 89.3,14872
Hib,Primary Series,HHS Regions/National,United States,2013,19 Months,92.7,92.0 to 93.4,14872
Hib,Primary Series,HHS Regions/National,United States,2013,24 Months,93.5,92.7 to 94.2,14872
Hib,Primary Series,HHS Regions/National,United States,2013,35 Months,94.8,94.1 to 95.5,14872
Hib,Primary Series,HHS Regions/National,United States,2013,7 Months,68.7,67.3 to 70.1,14872
Influenza,,HHS Regions/National,United States,2013,24 Months,53.7,52.1 to 55.3,14872
Influenza,,HHS Regions/National,United States,2013,35 Months,53.7,52.1 to 55.3,14872
MMR,³1 Dose,HHS Regions/National,United States,2013,13 Months,54,52.3 to 55.7,14872
MMR,³1 Dose,HHS Regions/National,United States,2013,19 Months,87.1,86.2 to 88.0,14872
MMR,³1 Dose,HHS Regions/National,United States,2013,24 Months,90.3,89.2 to 91.2,14872
MMR,³1 Dose,HHS Regions/National,United States,2013,35 Months,93.1,92.2 to 93.9,14872
PCV,³1 Dose,HHS Regions/National,United States,2013,3 Months,84.7,83.4 to 85.9,14872
PCV,³2 Doses,HHS Regions/National,United States,2013,5 Months,74.2,72.8 to 75.6,14872
PCV,³3 Doses,HHS Regions/National,United States,2013,13 Months,88.2,87.2 to 89.2,14872
PCV,³3 Doses,HHS Regions/National,United States,2013,19 Months,91.5,90.7 to 92.3,14872
PCV,³3 Doses,HHS Regions/National,United States,2013,24 Months,92.5,91.7 to 93.3,14872
PCV,³3 Doses,HHS Regions/National,United States,2013,35 Months,94,93.3 to 94.8,14872
PCV,³3 Doses,HHS Regions/National,United States,2013,7 Months,64.7,63.3 to 66.1,14872
PCV,³4 Doses,HHS Regions/National,United States,2013,19 Months,77.6,76.3 to 78.9,14872
PCV,³4 Doses,HHS Regions/National,United States,2013,24 Months,81.7,80.4 to 82.9,14872
PCV,³4 Doses,HHS Regions/National,United States,2013,35 Months,85.1,83.8 to 86.3,14872
Polio,³1 Dose,HHS Regions/National,United States,2013,3 Months,85.8,84.8 to 86.8,14872
Polio,³2 Doses,HHS Regions/National,United States,2013,13 Months,94,93.4 to 94.6,14872
Polio,³2 Doses,HHS Regions/National,United States,2013,5 Months,75.3,73.8 to 76.8,14872
Polio,³2 Doses,HHS Regions/National,United States,2013,7 Months,88.6,87.7 to 89.5,14872
Polio,³3 Doses,HHS Regions/National,United States,2013,19 Months,90.8,90.0 to 91.5,14872
Polio,³3 Doses,HHS Regions/National,United States,2013,24 Months,92.3,91.5 to 93.1,14872
Polio,³3 Doses,HHS Regions/National,United States,2013,35 Months,94.4,93.6 to 95.2,14872
Rotavirus,,HHS Regions/National,United States,2013,8 Months,72.5,71.1 to 73.9,14872
Varicella,³1 Dose,HHS Regions/National,United States,2013,13 Months,56.3,54.6 to 58.1,14872
Varicella,³1 Dose,HHS Regions/National,United States,2013,19 Months,86.8,85.8 to 87.7,14872
Varicella,³1 Dose,HHS Regions/National,United States,2013,24 Months,89.6,88.5 to 90.6,14872
Varicella,³1 Dose,HHS Regions/National,United States,2013,35 Months,92.9,91.9 to 93.7,14872
Combined 7 Series,,HHS Regions/National,United States,2014,24 Months,68.5,67.0 to 70.1,15333
Combined 7 Series,,HHS Regions/National,United States,2014,35 Months,74.1,72.5 to 75.7,15333
DTaP,³1 Dose,HHS Regions/National,United States,2014,3 Months,86.8,85.7 to 87.9,15333
DTaP,³2 Doses,HHS Regions/National,United States,2014,5 Months,77.8,76.4 to 79.2,15333
DTaP,³3 Doses,HHS Regions/National,United States,2014,13 Months,88.4,87.2 to 89.4,15333
DTaP,³3 Doses,HHS Regions/National,United States,2014,19 Months,91.5,90.4 to 92.4,15333
DTaP,³3 Doses,HHS Regions/National,United States,2014,24 Months,93,92.1 to 93.9,15333
DTaP,³3 Doses,HHS Regions/National,United States,2014,35 Months,94.5,93.5 to 95.3,15333
DTaP,³3 Doses,HHS Regions/National,United States,2014,7 Months,67.8,66.2 to 69.3,15333
DTaP,³4 Doses,HHS Regions/National,United States,2014,19 Months,69.1,67.5 to 70.6,15333
DTaP,³4 Doses,HHS Regions/National,United States,2014,24 Months,80.1,78.7 to 81.5,15333
DTaP,³4 Doses,HHS Regions/National,United States,2014,35 Months,87.5,85.8 to 89.1,15333
Hep A,³1 Dose,HHS Regions/National,United States,2014,19 Months,78.8,77.4 to 80.0,15333
Hep A,³1 Dose,HHS Regions/National,United States,2014,24 Months,83.4,82.1 to 84.6,15333
Hep A,³1 Dose,HHS Regions/National,United States,2014,35 Months,88.5,87.2 to 89.7,15333
Hep A,³2 Doses,HHS Regions/National,United States,2014,19 Months,23.6,22.3 to 25.1,15333
Hep A,³2 Doses,HHS Regions/National,United States,2014,24 Months,43.5,41.8 to 45.2,15333
Hep A,³2 Doses,HHS Regions/National,United States,2014,35 Months,73.6,71.8 to 75.4,15333
Hep B,³1 Dose,HHS Regions/National,United States,2014,3 Months,93.4,92.5 to 94.3,15333
Hep B,"³1 Dose, 1 Day",HHS Regions/National,United States,2014,0-1 Days,63.8,62.1 to 65.4,15333
Hep B,"³1 Dose, 2 Day",HHS Regions/National,United States,2014,0-2 Days,69.4,67.8 to 71.0,15333
Hep B,"³1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2014,0-3 Days,70.9,69.3 to 72.5,15333
Hep B,³2 Doses,HHS Regions/National,United States,2014,13 Months,92.9,91.9 to 93.7,15333
Hep B,³2 Doses,HHS Regions/National,United States,2014,5 Months,85.3,84.0 to 86.5,15333
Hep B,³2 Doses,HHS Regions/National,United States,2014,7 Months,89.8,88.7 to 90.9,15333
Hep B,³3 Doses,HHS Regions/National,United States,2014,13 Months,85.7,84.4 to 86.9,15333
Hep B,³3 Doses,HHS Regions/National,United States,2014,19 Months,88.9,87.7 to 90.0,15333
Hep B,³3 Doses,HHS Regions/National,United States,2014,24 Months,90.2,89.1 to 91.2,15333
Hep B,³3 Doses,HHS Regions/National,United States,2014,35 Months,91.8,90.7 to 92.9,15333
Hep B,³3 Doses,HHS Regions/National,United States,2014,7 Months,58.9,57.3 to 60.4,15333
Hib,³1 Dose,HHS Regions/National,United States,2014,3 Months,85,83.8 to 86.2,15333
Hib,³2 Doses,HHS Regions/National,United States,2014,13 Months,92.7,91.9 to 93.5,15333
Hib,³2 Doses,HHS Regions/National,United States,2014,5 Months,76.3,74.9 to 77.7,15333
Hib,³2 Doses,HHS Regions/National,United States,2014,7 Months,88.2,87.0 to 89.3,15333
Hib,³3 Doses,HHS Regions/National,United States,2014,13 Months,75.3,73.9 to 76.6,15333
Hib,³3 Doses,HHS Regions/National,United States,2014,19 Months,88.5,87.4 to 89.6,15333
Hib,³3 Doses,HHS Regions/National,United States,2014,24 Months,90.5,89.4 to 91.5,15333
Hib,³3 Doses,HHS Regions/National,United States,2014,35 Months,91.8,90.8 to 92.8,15333
Hib,³3 Doses,HHS Regions/National,United States,2014,7 Months,53.7,52.1 to 55.3,15333
Hib,Full Series,HHS Regions/National,United States,2014,19 Months,73.4,71.9 to 74.8,15333
Hib,Full Series,HHS Regions/National,United States,2014,24 Months,79.5,78.2 to 80.9,15333
Hib,Full Series,HHS Regions/National,United States,2014,35 Months,84,82.1 to 85.7,15333
Hib,Primary Series,HHS Regions/National,United States,2014,13 Months,87.2,86.0 to 88.2,15333
Hib,Primary Series,HHS Regions/National,United States,2014,19 Months,90.9,89.9 to 91.9,15333
Hib,Primary Series,HHS Regions/National,United States,2014,24 Months,91.9,90.9 to 92.8,15333
Hib,Primary Series,HHS Regions/National,United States,2014,35 Months,92.7,91.7 to 93.6,15333
Hib,Primary Series,HHS Regions/National,United States,2014,7 Months,70,68.5 to 71.6,15333
Influenza,,HHS Regions/National,United States,2014,24 Months,52.3,50.6 to 53.9,15333
Influenza,,HHS Regions/National,United States,2014,35 Months,52.3,50.6 to 53.9,15333
MMR,³1 Dose,HHS Regions/National,United States,2014,13 Months,60.7,59.1 to 62.2,15333
MMR,³1 Dose,HHS Regions/National,United States,2014,19 Months,87.2,86.1 to 88.2,15333
MMR,³1 Dose,HHS Regions/National,United States,2014,24 Months,89.8,88.7 to 90.8,15333
MMR,³1 Dose,HHS Regions/National,United States,2014,35 Months,93,91.9 to 94.1,15333
PCV,³1 Dose,HHS Regions/National,United States,2014,3 Months,83.2,81.9 to 84.5,15333
PCV,³2 Doses,HHS Regions/National,United States,2014,5 Months,74.4,72.9 to 75.8,15333
PCV,³3 Doses,HHS Regions/National,United States,2014,13 Months,86.1,84.8 to 87.3,15333
PCV,³3 Doses,HHS Regions/National,United States,2014,19 Months,89.7,88.5 to 90.8,15333
PCV,³3 Doses,HHS Regions/National,United States,2014,24 Months,91.2,90.1 to 92.2,15333
PCV,³3 Doses,HHS Regions/National,United States,2014,35 Months,92.1,91.0 to 93.1,15333
PCV,³3 Doses,HHS Regions/National,United States,2014,7 Months,63.5,61.9 to 65.1,15333
PCV,³4 Doses,HHS Regions/National,United States,2014,19 Months,77,75.5 to 78.4,15333
PCV,³4 Doses,HHS Regions/National,United States,2014,24 Months,81.3,80.0 to 82.6,15333
PCV,³4 Doses,HHS Regions/National,United States,2014,35 Months,84.1,82.7 to 85.4,15333
Polio,³1 Dose,HHS Regions/National,United States,2014,3 Months,85.3,84.1 to 86.4,15333
Polio,³2 Doses,HHS Regions/National,United States,2014,13 Months,92.8,91.9 to 93.6,15333
Polio,³2 Doses,HHS Regions/National,United States,2014,5 Months,76.5,75.1 to 77.9,15333
Polio,³2 Doses,HHS Regions/National,United States,2014,7 Months,88.2,87.0 to 89.2,15333
Polio,³3 Doses,HHS Regions/National,United States,2014,19 Months,89.2,88.0 to 90.2,15333
Polio,³3 Doses,HHS Regions/National,United States,2014,24 Months,91,89.9 to 92.1,15333
Polio,³3 Doses,HHS Regions/National,United States,2014,35 Months,93.2,92.1 to 94.2,15333
Rotavirus,,HHS Regions/National,United States,2014,8 Months,72.3,70.8 to 73.8,15333
Varicella,³1 Dose,HHS Regions/National,United States,2014,13 Months,57.8,56.2 to 59.4,15333
Varicella,³1 Dose,HHS Regions/National,United States,2014,19 Months,86.8,85.7 to 87.9,15333
Varicella,³1 Dose,HHS Regions/National,United States,2014,24 Months,89.1,88.0 to 90.1,15333
Varicella,³1 Dose,HHS Regions/National,United States,2014,35 Months,93.1,91.6 to 94.4,15333
Combined 7 Series,,HHS Regions/National,United States,2015,24 Months,68.3,66.7 to 69.9,15463
Combined 7 Series,,HHS Regions/National,United States,2015,35 Months,74.9,73.3 to 76.5,15463
DTaP,³1 Dose,HHS Regions/National,United States,2015,3 Months,87.8,86.7 to 88.9,15463
DTaP,³2 Doses,HHS Regions/National,United States,2015,5 Months,78.5,77.0 to 79.9,15463
DTaP,³3 Doses,HHS Regions/National,United States,2015,13 Months,89.7,88.6 to 90.7,15463
DTaP,³3 Doses,HHS Regions/National,United States,2015,19 Months,92.9,92.0 to 93.6,15463
DTaP,³3 Doses,HHS Regions/National,United States,2015,24 Months,93.9,93.1 to 94.6,15463
DTaP,³3 Doses,HHS Regions/National,United States,2015,35 Months,95.3,94.6 to 96.0,15463
DTaP,³3 Doses,HHS Regions/National,United States,2015,7 Months,68.1,66.4 to 69.8,15463
DTaP,³4 Doses,HHS Regions/National,United States,2015,19 Months,69.6,68.0 to 71.1,15463
DTaP,³4 Doses,HHS Regions/National,United States,2015,24 Months,80.7,79.4 to 82.0,15463
DTaP,³4 Doses,HHS Regions/National,United States,2015,35 Months,88.1,86.8 to 89.4,15463
Hep A,³1 Dose,HHS Regions/National,United States,2015,19 Months,79.6,77.7 to 81.3,15463
Hep A,³1 Dose,HHS Regions/National,United States,2015,24 Months,84.6,83.4 to 85.7,15463
Hep A,³1 Dose,HHS Regions/National,United States,2015,35 Months,90.2,89.1 to 91.2,15463
Hep A,³2 Doses,HHS Regions/National,United States,2015,19 Months,24.1,23.0 to 25.3,15463
Hep A,³2 Doses,HHS Regions/National,United States,2015,24 Months,43.3,41.5 to 45.1,15463
Hep A,³2 Doses,HHS Regions/National,United States,2015,35 Months,76.4,74.3 to 78.5,15463
Hep B,³1 Dose,HHS Regions/National,United States,2015,3 Months,93.7,92.7 to 94.6,15463
Hep B,"³1 Dose, 1 Day",HHS Regions/National,United States,2015,0-1 Days,64.8,63.0 to 66.5,15463
Hep B,"³1 Dose, 2 Day",HHS Regions/National,United States,2015,0-2 Days,71.7,70.0 to 73.4,15463
Hep B,"³1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2015,0-3 Days,73.3,71.6 to 75.0,15463
Hep B,³2 Doses,HHS Regions/National,United States,2015,13 Months,93.5,92.6 to 94.4,15463
Hep B,³2 Doses,HHS Regions/National,United States,2015,5 Months,86.2,84.8 to 87.4,15463
Hep B,³2 Doses,HHS Regions/National,United States,2015,7 Months,90.3,89.2 to 91.4,15463
Hep B,³3 Doses,HHS Regions/National,United States,2015,13 Months,86.4,85.1 to 87.6,15463
Hep B,³3 Doses,HHS Regions/National,United States,2015,19 Months,89.6,88.8 to 90.4,15463
Hep B,³3 Doses,HHS Regions/National,United States,2015,24 Months,90.6,89.5 to 91.6,15463
Hep B,³3 Doses,HHS Regions/National,United States,2015,35 Months,92.5,91.5 to 93.5,15463
Hep B,³3 Doses,HHS Regions/National,United States,2015,7 Months,59.1,57.4 to 60.9,15463
Hib,³1 Dose,HHS Regions/National,United States,2015,3 Months,86.4,85.1 to 87.5,15463
Hib,³2 Doses,HHS Regions/National,United States,2015,13 Months,93.4,92.5 to 94.1,15463
Hib,³2 Doses,HHS Regions/National,United States,2015,5 Months,76.7,75.2 to 78.2,15463
Hib,³2 Doses,HHS Regions/National,United States,2015,7 Months,88.7,87.5 to 89.7,15463
Hib,³3 Doses,HHS Regions/National,United States,2015,13 Months,76.1,74.7 to 77.4,15463
Hib,³3 Doses,HHS Regions/National,United States,2015,19 Months,89.2,88.3 to 90.0,15463
Hib,³3 Doses,HHS Regions/National,United States,2015,24 Months,91.1,90.1 to 92.0,15463
Hib,³3 Doses,HHS Regions/National,United States,2015,35 Months,93.2,92.2 to 94.1,15463
Hib,³3 Doses,HHS Regions/National,United States,2015,7 Months,52.4,50.6 to 54.1,15463
Hib,Full Series,HHS Regions/National,United States,2015,19 Months,73.7,72.1 to 75.2,15463
Hib,Full Series,HHS Regions/National,United States,2015,24 Months,79.6,78.3 to 81.0,15463
Hib,Full Series,HHS Regions/National,United States,2015,35 Months,83.6,82.2 to 84.9,15463
Hib,Primary Series,HHS Regions/National,United States,2015,13 Months,87.8,86.6 to 88.8,15463
Hib,Primary Series,HHS Regions/National,United States,2015,19 Months,92.1,91.4 to 92.7,15463
Hib,Primary Series,HHS Regions/National,United States,2015,24 Months,92.8,91.9 to 93.6,15463
Hib,Primary Series,HHS Regions/National,United States,2015,35 Months,94.3,93.4 to 95.1,15463
Hib,Primary Series,HHS Regions/National,United States,2015,7 Months,68.7,66.9 to 70.4,15463
Influenza,,HHS Regions/National,United States,2015,24 Months,55.3,53.6 to 57.0,15463
Influenza,,HHS Regions/National,United States,2015,35 Months,55.3,53.6 to 57.0,15463
MMR,³1 Dose,HHS Regions/National,United States,2015,13 Months,60,58.3 to 61.7,15463
MMR,³1 Dose,HHS Regions/National,United States,2015,19 Months,87.4,86.3 to 88.3,15463
MMR,³1 Dose,HHS Regions/National,United States,2015,24 Months,90.8,89.9 to 91.6,15463
MMR,³1 Dose,HHS Regions/National,United States,2015,35 Months,93.4,92.6 to 94.2,15463
PCV,³1 Dose,HHS Regions/National,United States,2015,3 Months,84.9,83.7 to 86.1,15463
PCV,³2 Doses,HHS Regions/National,United States,2015,5 Months,75.3,73.8 to 76.8,15463
PCV,³3 Doses,HHS Regions/National,United States,2015,13 Months,87.3,86.1 to 88.4,15463
PCV,³3 Doses,HHS Regions/National,United States,2015,19 Months,90.8,89.9 to 91.6,15463
PCV,³3 Doses,HHS Regions/National,United States,2015,24 Months,91.8,90.8 to 92.7,15463
PCV,³3 Doses,HHS Regions/National,United States,2015,35 Months,93.7,92.6 to 94.6,15463
PCV,³3 Doses,HHS Regions/National,United States,2015,7 Months,63.7,61.9 to 65.4,15463
PCV,³4 Doses,HHS Regions/National,United States,2015,19 Months,76.3,74.9 to 77.7,15463
PCV,³4 Doses,HHS Regions/National,United States,2015,24 Months,81,79.7 to 82.3,15463
PCV,³4 Doses,HHS Regions/National,United States,2015,35 Months,84.4,83.1 to 85.7,15463
Polio,³1 Dose,HHS Regions/National,United States,2015,3 Months,86.3,85.1 to 87.5,15463
Polio,³2 Doses,HHS Regions/National,United States,2015,13 Months,93.4,92.4 to 94.2,15463
Polio,³2 Doses,HHS Regions/National,United States,2015,5 Months,76.8,75.2 to 78.3,15463
Polio,³2 Doses,HHS Regions/National,United States,2015,7 Months,89.1,88.0 to 90.1,15463
Polio,³3 Doses,HHS Regions/National,United States,2015,19 Months,91.1,89.9 to 92.1,15463
Polio,³3 Doses,HHS Regions/National,United States,2015,24 Months,92.6,91.7 to 93.4,15463
Polio,³3 Doses,HHS Regions/National,United States,2015,35 Months,94.3,93.5 to 95.1,15463
Rotavirus,,HHS Regions/National,United States,2015,8 Months,72.1,70.4 to 73.7,15463
Varicella,³1 Dose,HHS Regions/National,United States,2015,13 Months,57.3,55.6 to 59.0,15463
Varicella,³1 Dose,HHS Regions/National,United States,2015,19 Months,86.8,85.8 to 87.8,15463
Varicella,³1 Dose,HHS Regions/National,United States,2015,24 Months,90.2,89.3 to 91.1,15463
Varicella,³1 Dose,HHS Regions/National,United States,2015,35 Months,93,92.2 to 93.8,15463
Combined 7 Series,,HHS Regions/National,United States,2016,24 Months,69.7,68.0 to 71.3,15956
Combined 7 Series,,HHS Regions/National,United States,2016,35 Months,75.3,73.6 to 77.0,15956
DTaP,³1 Dose,HHS Regions/National,United States,2016,3 Months,88.5,87.3 to 89.6,15956
DTaP,³2 Doses,HHS Regions/National,United States,2016,5 Months,79.2,77.6 to 80.7,15956
DTaP,³3 Doses,HHS Regions/National,United States,2016,13 Months,89.2,87.9 to 90.4,15956
DTaP,³3 Doses,HHS Regions/National,United States,2016,19 Months,92.6,91.8 to 93.4,15956
DTaP,³3 Doses,HHS Regions/National,United States,2016,24 Months,93.7,92.8 to 94.4,15956
DTaP,³3 Doses,HHS Regions/National,United States,2016,35 Months,94.6,93.7 to 95.4,15956
DTaP,³3 Doses,HHS Regions/National,United States,2016,7 Months,71.4,69.7 to 73.0,15956
DTaP,³4 Doses,HHS Regions/National,United States,2016,19 Months,70,68.3 to 71.6,15956
DTaP,³4 Doses,HHS Regions/National,United States,2016,24 Months,80.4,78.9 to 81.8,15956
DTaP,³4 Doses,HHS Regions/National,United States,2016,35 Months,87.8,86.4 to 89.2,15956
Hep A,³1 Dose,HHS Regions/National,United States,2016,19 Months,80.8,79.4 to 82.2,15956
Hep A,³1 Dose,HHS Regions/National,United States,2016,24 Months,85.3,84.1 to 86.5,15956
Hep A,³1 Dose,HHS Regions/National,United States,2016,35 Months,89.9,88.7 to 91.1,15956
Hep A,³2 Doses,HHS Regions/National,United States,2016,19 Months,26,24.5 to 27.5,15956
Hep A,³2 Doses,HHS Regions/National,United States,2016,24 Months,44.8,43.0 to 46.6,15956
Hep A,³2 Doses,HHS Regions/National,United States,2016,35 Months,76.2,74.3 to 78.0,15956
Hep B,³1 Dose,HHS Regions/National,United States,2016,3 Months,94.8,93.8 to 95.6,15956
Hep B,"³1 Dose, 1 Day",HHS Regions/National,United States,2016,0-1 Days,68.1,66.5 to 69.7,15956
Hep B,"³1 Dose, 2 Day",HHS Regions/National,United States,2016,0-2 Days,74.1,72.5 to 75.6,15956
Hep B,"³1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2016,0-3 Days,75.6,74.0 to 77.1,15956
Hep B,³2 Doses,HHS Regions/National,United States,2016,13 Months,94.3,93.5 to 95.0,15956
Hep B,³2 Doses,HHS Regions/National,United States,2016,5 Months,87.6,86.2 to 88.9,15956
Hep B,³2 Doses,HHS Regions/National,United States,2016,7 Months,91.5,90.4 to 92.5,15956
Hep B,³3 Doses,HHS Regions/National,United States,2016,13 Months,87.6,86.4 to 88.7,15956
Hep B,³3 Doses,HHS Regions/National,United States,2016,19 Months,90.6,89.5 to 91.5,15956
Hep B,³3 Doses,HHS Regions/National,United States,2016,24 Months,91.4,90.4 to 92.3,15956
Hep B,³3 Doses,HHS Regions/National,United States,2016,35 Months,92.5,91.5 to 93.5,15956
Hep B,³3 Doses,HHS Regions/National,United States,2016,7 Months,60,58.2 to 61.7,15956
Hib,³1 Dose,HHS Regions/National,United States,2016,3 Months,86.8,85.6 to 88.0,15956
Hib,³2 Doses,HHS Regions/National,United States,2016,13 Months,93.3,92.4 to 94.2,15956
Hib,³2 Doses,HHS Regions/National,United States,2016,5 Months,77.6,76.0 to 79.1,15956
Hib,³2 Doses,HHS Regions/National,United States,2016,7 Months,89,87.7 to 90.2,15956
Hib,³3 Doses,HHS Regions/National,United States,2016,13 Months,74.3,72.8 to 75.8,15956
Hib,³3 Doses,HHS Regions/National,United States,2016,19 Months,89.1,88.0 to 90.2,15956
Hib,³3 Doses,HHS Regions/National,United States,2016,24 Months,91,89.9 to 92.0,15956
Hib,³3 Doses,HHS Regions/National,United States,2016,35 Months,92.6,91.5 to 93.6,15956
Hib,³3 Doses,HHS Regions/National,United States,2016,7 Months,54.6,52.9 to 56.3,15956
Hib,Full Series,HHS Regions/National,United States,2016,19 Months,74.6,73.0 to 76.1,15956
Hib,Full Series,HHS Regions/National,United States,2016,24 Months,80,78.6 to 81.5,15956
Hib,Full Series,HHS Regions/National,United States,2016,35 Months,83.6,82.1 to 85.0,15956
Hib,Primary Series,HHS Regions/National,United States,2016,13 Months,87.3,85.9 to 88.5,15956
Hib,Primary Series,HHS Regions/National,United States,2016,19 Months,91.8,90.8 to 92.8,15956
Hib,Primary Series,HHS Regions/National,United States,2016,24 Months,92.7,91.7 to 93.6,15956
Hib,Primary Series,HHS Regions/National,United States,2016,35 Months,93.4,92.5 to 94.3,15956
Hib,Primary Series,HHS Regions/National,United States,2016,7 Months,72,70.3 to 73.5,15956
Influenza,,HHS Regions/National,United States,2016,24 Months,56.7,55.0 to 58.4,15956
Influenza,,HHS Regions/National,United States,2016,35 Months,56.7,55.0 to 58.4,15956
MMR,³1 Dose,HHS Regions/National,United States,2016,13 Months,61.8,60.2 to 63.4,15956
MMR,³1 Dose,HHS Regions/National,United States,2016,19 Months,87.3,86.1 to 88.4,15956
MMR,³1 Dose,HHS Regions/National,United States,2016,24 Months,90.8,89.8 to 91.7,15956
MMR,³1 Dose,HHS Regions/National,United States,2016,35 Months,93.3,92.3 to 94.1,15956
PCV,³1 Dose,HHS Regions/National,United States,2016,3 Months,86.3,85.0 to 87.5,15956
PCV,³2 Doses,HHS Regions/National,United States,2016,5 Months,76.8,75.3 to 78.4,15956
PCV,³3 Doses,HHS Regions/National,United States,2016,13 Months,87.6,86.2 to 88.8,15956
PCV,³3 Doses,HHS Regions/National,United States,2016,19 Months,90.9,89.9 to 91.9,15956
PCV,³3 Doses,HHS Regions/National,United States,2016,24 Months,92,91.1 to 92.9,15956
PCV,³3 Doses,HHS Regions/National,United States,2016,35 Months,93,92.0 to 93.9,15956
PCV,³3 Doses,HHS Regions/National,United States,2016,7 Months,67.9,66.2 to 69.5,15956
PCV,³4 Doses,HHS Regions/National,United States,2016,19 Months,77.2,75.7 to 78.7,15956
PCV,³4 Doses,HHS Regions/National,United States,2016,24 Months,81.4,79.9 to 82.9,15956
PCV,³4 Doses,HHS Regions/National,United States,2016,35 Months,84.5,83.0 to 85.9,15956
Polio,³1 Dose,HHS Regions/National,United States,2016,3 Months,87.4,86.2 to 88.6,15956
Polio,³2 Doses,HHS Regions/National,United States,2016,13 Months,93.2,92.2 to 94.1,15956
Polio,³2 Doses,HHS Regions/National,United States,2016,5 Months,78,76.4 to 79.5,15956
Polio,³2 Doses,HHS Regions/National,United States,2016,7 Months,88.9,87.6 to 90.1,15956
Polio,³3 Doses,HHS Regions/National,United States,2016,19 Months,91.3,90.3 to 92.2,15956
Polio,³3 Doses,HHS Regions/National,United States,2016,24 Months,92.5,91.6 to 93.4,15956
Polio,³3 Doses,HHS Regions/National,United States,2016,35 Months,94.2,93.2 to 95.2,15956
Rotavirus,,HHS Regions/National,United States,2016,8 Months,75.1,73.5 to 76.6,15956
Varicella,³1 Dose,HHS Regions/National,United States,2016,13 Months,59.8,58.2 to 61.4,15956
Varicella,³1 Dose,HHS Regions/National,United States,2016,19 Months,86.6,85.4 to 87.8,15956
Varicella,³1 Dose,HHS Regions/National,United States,2016,24 Months,90.3,89.3 to 91.3,15956
Varicella,³1 Dose,HHS Regions/National,United States,2016,35 Months,93.5,92.6 to 94.3,15956
Combined 7 Series,,HHS Regions/National,United States,2017,24 Months,69.8,68.4 to 71.3,17804
Combined 7 Series,,HHS Regions/National,United States,2017,35 Months,74.9,73.3 to 76.4,17804
DTaP,³1 Dose,HHS Regions/National,United States,2017,3 Months,87.1,86.0 to 88.2,17804
DTaP,³2 Doses,HHS Regions/National,United States,2017,5 Months,78.4,77.1 to 79.8,17804
DTaP,³3 Doses,HHS Regions/National,United States,2017,13 Months,88.9,87.9 to 89.9,17804
DTaP,³3 Doses,HHS Regions/National,United States,2017,19 Months,91.9,91.0 to 92.7,17804
DTaP,³3 Doses,HHS Regions/National,United States,2017,24 Months,92.6,91.8 to 93.5,17804
DTaP,³3 Doses,HHS Regions/National,United States,2017,35 Months,93.8,92.9 to 94.6,17804
DTaP,³3 Doses,HHS Regions/National,United States,2017,7 Months,69.9,68.4 to 71.4,17804
DTaP,³4 Doses,HHS Regions/National,United States,2017,19 Months,71.6,70.1 to 72.9,17804
DTaP,³4 Doses,HHS Regions/National,United States,2017,24 Months,80.9,79.7 to 82.1,17804
DTaP,³4 Doses,HHS Regions/National,United States,2017,35 Months,87.5,86.2 to 88.8,17804
Hep A,³1 Dose,HHS Regions/National,United States,2017,19 Months,81.8,80.5 to 82.9,17804
Hep A,³1 Dose,HHS Regions/National,United States,2017,24 Months,85.9,84.8 to 87.0,17804
Hep A,³1 Dose,HHS Regions/National,United States,2017,35 Months,90.2,89.1 to 91.3,17804
Hep A,³2 Doses,HHS Regions/National,United States,2017,19 Months,27,25.7 to 28.3,17804
Hep A,³2 Doses,HHS Regions/National,United States,2017,24 Months,45.6,44.1 to 47.2,17804
Hep A,³2 Doses,HHS Regions/National,United States,2017,35 Months,77.4,75.8 to 79.1,17804
Hep B,³1 Dose,HHS Regions/National,United States,2017,3 Months,95.1,94.4 to 95.8,17804
Hep B,"³1 Dose, 1 Day",HHS Regions/National,United States,2017,0-1 Days,70.2,68.8 to 71.5,17804
Hep B,"³1 Dose, 2 Day",HHS Regions/National,United States,2017,0-2 Days,75.6,74.2 to 76.8,17804
Hep B,"³1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2017,0-3 Days,77.1,75.0 to 79.0,10014
Hep B,³2 Doses,HHS Regions/National,United States,2017,13 Months,93.8,93.0 to 94.6,17804
Hep B,³2 Doses,HHS Regions/National,United States,2017,5 Months,87.4,86.3 to 88.4,17804
Hep B,³2 Doses,HHS Regions/National,United States,2017,7 Months,90.9,89.9 to 91.8,17804
Hep B,³3 Doses,HHS Regions/National,United States,2017,13 Months,87.3,86.3 to 88.3,17804
Hep B,³3 Doses,HHS Regions/National,United States,2017,19 Months,90.2,89.3 to 91.1,17804
Hep B,³3 Doses,HHS Regions/National,United States,2017,24 Months,91.1,90.2 to 92.0,17804
Hep B,³3 Doses,HHS Regions/National,United States,2017,35 Months,92.7,91.7 to 93.6,17804
Hep B,³3 Doses,HHS Regions/National,United States,2017,7 Months,59.5,58.0 to 61.0,17804
Hib,³1 Dose,HHS Regions/National,United States,2017,3 Months,86.1,84.9 to 87.2,17804
Hib,³2 Doses,HHS Regions/National,United States,2017,13 Months,93,92.2 to 93.8,17804
Hib,³2 Doses,HHS Regions/National,United States,2017,5 Months,77.2,75.8 to 78.6,17804
Hib,³2 Doses,HHS Regions/National,United States,2017,7 Months,88.5,87.4 to 89.5,17804
Hib,³3 Doses,HHS Regions/National,United States,2017,13 Months,75,73.7 to 76.2,17804
Hib,³3 Doses,HHS Regions/National,United States,2017,19 Months,88.8,87.7 to 89.7,17804
Hib,³3 Doses,HHS Regions/National,United States,2017,24 Months,90.5,89.5 to 91.4,17804
Hib,³3 Doses,HHS Regions/National,United States,2017,35 Months,91.8,90.8 to 92.7,17804
Hib,³3 Doses,HHS Regions/National,United States,2017,7 Months,55.5,54.0 to 57.0,17804
Hib,Full Series,HHS Regions/National,United States,2017,19 Months,74.4,73.0 to 75.7,17804
Hib,Full Series,HHS Regions/National,United States,2017,24 Months,79.1,77.8 to 80.5,17804
Hib,Full Series,HHS Regions/National,United States,2017,35 Months,83,81.5 to 84.4,17804
Hib,Primary Series,HHS Regions/National,United States,2017,13 Months,87,85.9 to 88.1,17804
Hib,Primary Series,HHS Regions/National,United States,2017,19 Months,91.2,90.2 to 92.1,17804
Hib,Primary Series,HHS Regions/National,United States,2017,24 Months,92,91.1 to 92.9,17804
Hib,Primary Series,HHS Regions/National,United States,2017,35 Months,92.9,92.0 to 93.7,17804
Hib,Primary Series,HHS Regions/National,United States,2017,7 Months,72.2,70.8 to 73.6,17804
Influenza,,HHS Regions/National,United States,2017,24 Months,58.2,56.7 to 59.7,17804
Influenza,,HHS Regions/National,United States,2017,35 Months,58.2,56.7 to 59.7,17804
MMR,³1 Dose,HHS Regions/National,United States,2017,13 Months,62.1,60.6 to 63.6,17804
MMR,³1 Dose,HHS Regions/National,United States,2017,19 Months,87.5,86.4 to 88.6,17804
MMR,³1 Dose,HHS Regions/National,United States,2017,24 Months,90.4,89.3 to 91.3,17804
MMR,³1 Dose,HHS Regions/National,United States,2017,35 Months,92.4,91.3 to 93.4,17804
PCV,³1 Dose,HHS Regions/National,United States,2017,3 Months,84.9,83.7 to 86.0,17804
PCV,³2 Doses,HHS Regions/National,United States,2017,5 Months,76.1,74.7 to 77.4,17804
PCV,³3 Doses,HHS Regions/National,United States,2017,13 Months,87.1,86.0 to 88.2,17804
PCV,³3 Doses,HHS Regions/National,United States,2017,19 Months,90.4,89.4 to 91.3,17804
PCV,³3 Doses,HHS Regions/National,United States,2017,24 Months,91.3,90.3 to 92.1,17804
PCV,³3 Doses,HHS Regions/National,United States,2017,35 Months,92.5,91.5 to 93.4,17804
PCV,³3 Doses,HHS Regions/National,United States,2017,7 Months,66.7,65.2 to 68.2,17804
PCV,³4 Doses,HHS Regions/National,United States,2017,19 Months,77.4,76.0 to 78.8,17804
PCV,³4 Doses,HHS Regions/National,United States,2017,24 Months,80.9,79.6 to 82.2,17804
PCV,³4 Doses,HHS Regions/National,United States,2017,35 Months,83.2,81.9 to 84.5,17804
Polio,³1 Dose,HHS Regions/National,United States,2017,3 Months,86.1,84.9 to 87.2,17804
Polio,³2 Doses,HHS Regions/National,United States,2017,13 Months,93.1,92.2 to 93.8,17804
Polio,³2 Doses,HHS Regions/National,United States,2017,5 Months,77.5,76.1 to 78.8,17804
Polio,³2 Doses,HHS Regions/National,United States,2017,7 Months,88.4,87.3 to 89.4,17804
Polio,³3 Doses,HHS Regions/National,United States,2017,19 Months,90.3,89.3 to 91.2,17804
Polio,³3 Doses,HHS Regions/National,United States,2017,24 Months,91.5,90.6 to 92.4,17804
Polio,³3 Doses,HHS Regions/National,United States,2017,35 Months,92.9,92.0 to 93.8,17804
Rotavirus,,HHS Regions/National,United States,2017,8 Months,74,72.6 to 75.4,17804
Varicella,³1 Dose,HHS Regions/National,United States,2017,13 Months,60,58.5 to 61.5,17804
Varicella,³1 Dose,HHS Regions/National,United States,2017,19 Months,86.8,85.7 to 87.9,17804
Varicella,³1 Dose,HHS Regions/National,United States,2017,24 Months,89.9,88.9 to 90.9,17804
Varicella,³1 Dose,HHS Regions/National,United States,2017,35 Months,92.9,91.9 to 93.8,17804
Combined 7 Series,,HHS Regions/National,United States,2018,24 Months,70.1,68.8 to 71.5,18826
Combined 7 Series,,HHS Regions/National,United States,2018,35 Months,76.1,74.7 to 77.5,18826
DTaP,³1 Dose,HHS Regions/National,United States,2018,3 Months,89.9,89.0 to 90.7,18826
DTaP,³2 Doses,HHS Regions/National,United States,2018,5 Months,81.6,80.4 to 82.7,18826
DTaP,³3 Doses,HHS Regions/National,United States,2018,13 Months,91,90.1 to 91.8,18826
DTaP,³3 Doses,HHS Regions/National,United States,2018,19 Months,93.7,93.0 to 94.4,18826
DTaP,³3 Doses,HHS Regions/National,United States,2018,24 Months,94.6,93.9 to 95.2,18826
DTaP,³3 Doses,HHS Regions/National,United States,2018,35 Months,95.7,95.0 to 96.4,18826
DTaP,³3 Doses,HHS Regions/National,United States,2018,7 Months,74,72.7 to 75.3,18826
DTaP,³4 Doses,HHS Regions/National,United States,2018,19 Months,72.2,70.9 to 73.5,18826
DTaP,³4 Doses,HHS Regions/National,United States,2018,24 Months,82.3,81.2 to 83.4,18826
DTaP,³4 Doses,HHS Regions/National,United States,2018,35 Months,89.3,88.1 to 90.3,18826
Hep A,³1 Dose,HHS Regions/National,United States,2018,19 Months,83.8,82.7 to 84.8,18826
Hep A,³1 Dose,HHS Regions/National,United States,2018,24 Months,87.9,86.9 to 88.9,18826
Hep A,³1 Dose,HHS Regions/National,United States,2018,35 Months,92.1,91.1 to 93.1,18826
Hep A,³2 Doses,HHS Regions/National,United States,2018,19 Months,26.9,25.7 to 28.1,18826
Hep A,³2 Doses,HHS Regions/National,United States,2018,24 Months,47.2,45.8 to 48.7,18826
Hep A,³2 Doses,HHS Regions/National,United States,2018,35 Months,78.9,77.2 to 80.6,18826
Hep B,³1 Dose,HHS Regions/National,United States,2018,3 Months,95.9,95.3 to 96.5,18826
Hep B,"³1 Dose, 1 Day",HHS Regions/National,United States,2018,0-1 Days,73.6,72.3 to 74.9,18826
Hep B,"³1 Dose, 2 Day",HHS Regions/National,United States,2018,0-2 Days,77.6,76.3 to 78.9,18826
Hep B,"³1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2018,0-3 Days,79.1,77.8 to 80.3,18826
Hep B,³2 Doses,HHS Regions/National,United States,2018,13 Months,95.4,94.7 to 96.0,18826
Hep B,³2 Doses,HHS Regions/National,United States,2018,5 Months,89.8,88.8 to 90.7,18826
Hep B,³2 Doses,HHS Regions/National,United States,2018,7 Months,92.9,92.1 to 93.6,18826
Hep B,³3 Doses,HHS Regions/National,United States,2018,13 Months,88.7,87.7 to 89.6,18826
Hep B,³3 Doses,HHS Regions/National,United States,2018,19 Months,91.8,91.0 to 92.6,18826
Hep B,³3 Doses,HHS Regions/National,United States,2018,24 Months,92.5,91.7 to 93.3,18826
Hep B,³3 Doses,HHS Regions/National,United States,2018,35 Months,93.9,93.0 to 94.6,18826
Hep B,³3 Doses,HHS Regions/National,United States,2018,7 Months,63.6,62.2 to 64.9,18826
Hib,³1 Dose,HHS Regions/National,United States,2018,3 Months,88.1,87.1 to 89.0,18826
Hib,³2 Doses,HHS Regions/National,United States,2018,13 Months,94.8,94.1 to 95.4,18826
Hib,³2 Doses,HHS Regions/National,United States,2018,5 Months,79.6,78.4 to 80.8,18826
Hib,³2 Doses,HHS Regions/National,United States,2018,7 Months,90.3,89.4 to 91.1,18826
Hib,³3 Doses,HHS Regions/National,United States,2018,13 Months,75.5,74.3 to 76.7,18826
Hib,³3 Doses,HHS Regions/National,United States,2018,19 Months,90.6,89.7 to 91.4,18826
Hib,³3 Doses,HHS Regions/National,United States,2018,24 Months,92,91.2 to 92.8,18826
Hib,³3 Doses,HHS Regions/National,United States,2018,35 Months,93.7,92.8 to 94.5,18826
Hib,³3 Doses,HHS Regions/National,United States,2018,7 Months,56.8,55.4 to 58.2,18826
Hib,Full Series,HHS Regions/National,United States,2018,19 Months,74.7,73.4 to 75.9,18826
Hib,Full Series,HHS Regions/National,United States,2018,24 Months,80.2,79.0 to 81.3,18826
Hib,Full Series,HHS Regions/National,United States,2018,35 Months,84,82.8 to 85.2,18826
Hib,Primary Series,HHS Regions/National,United States,2018,13 Months,88.3,87.3 to 89.2,18826
Hib,Primary Series,HHS Regions/National,United States,2018,19 Months,93,92.2 to 93.7,18826
Hib,Primary Series,HHS Regions/National,United States,2018,24 Months,93.6,92.8 to 94.3,18826
Hib,Primary Series,HHS Regions/National,United States,2018,35 Months,94.5,93.7 to 95.2,18826
Hib,Primary Series,HHS Regions/National,United States,2018,7 Months,73.7,72.4 to 75.0,18826
Influenza,,HHS Regions/National,United States,2018,24 Months,63.1,61.7 to 64.4,18826
Influenza,,HHS Regions/National,United States,2018,35 Months,63.1,61.7 to 64.4,18826
MMR,³1 Dose,HHS Regions/National,United States,2018,13 Months,68.5,67.1 to 69.9,18826
MMR,³1 Dose,HHS Regions/National,United States,2018,19 Months,90,89.1 to 90.8,18826
MMR,³1 Dose,HHS Regions/National,United States,2018,24 Months,92.3,91.5 to 93.0,18826
MMR,³1 Dose,HHS Regions/National,United States,2018,35 Months,94.7,93.9 to 95.4,18826
PCV,³1 Dose,HHS Regions/National,United States,2018,3 Months,87.6,86.7 to 88.6,18826
PCV,³2 Doses,HHS Regions/National,United States,2018,5 Months,79.1,77.9 to 80.3,18826
PCV,³3 Doses,HHS Regions/National,United States,2018,13 Months,89.7,88.8 to 90.6,18826
PCV,³3 Doses,HHS Regions/National,United States,2018,19 Months,92.9,92.2 to 93.6,18826
PCV,³3 Doses,HHS Regions/National,United States,2018,24 Months,93.6,92.9 to 94.2,18826
PCV,³3 Doses,HHS Regions/National,United States,2018,35 Months,94.7,94.0 to 95.4,18826
PCV,³3 Doses,HHS Regions/National,United States,2018,7 Months,70.3,69.0 to 71.6,18826
PCV,³4 Doses,HHS Regions/National,United States,2018,19 Months,79.7,78.5 to 80.8,18826
PCV,³4 Doses,HHS Regions/National,United States,2018,24 Months,83.6,82.5 to 84.6,18826
PCV,³4 Doses,HHS Regions/National,United States,2018,35 Months,86.8,85.7 to 87.9,18826
Polio,³1 Dose,HHS Regions/National,United States,2018,3 Months,89.2,88.3 to 90.1,18826
Polio,³2 Doses,HHS Regions/National,United States,2018,13 Months,95.1,94.4 to 95.7,18826
Polio,³2 Doses,HHS Regions/National,United States,2018,5 Months,80.6,79.4 to 81.8,18826
Polio,³2 Doses,HHS Regions/National,United States,2018,7 Months,90.8,89.9 to 91.6,18826
Polio,³3 Doses,HHS Regions/National,United States,2018,19 Months,92.8,92.0 to 93.5,18826
Polio,³3 Doses,HHS Regions/National,United States,2018,24 Months,93.8,93.1 to 94.4,18826
Polio,³3 Doses,HHS Regions/National,United States,2018,35 Months,94.9,94.1 to 95.6,18826
Rotavirus,,HHS Regions/National,United States,2018,8 Months,77.4,76.1 to 78.6,18826
Varicella,³1 Dose,HHS Regions/National,United States,2018,13 Months,62,60.6 to 63.4,18826
Varicella,³1 Dose,HHS Regions/National,United States,2018,19 Months,88.8,87.9 to 89.7,18826
Varicella,³1 Dose,HHS Regions/National,United States,2018,24 Months,91.2,90.3 to 92.0,18826
Varicella,³1 Dose,HHS Regions/National,United States,2018,35 Months,93.9,93.0 to 94.7,18826
Combined 7 Series,,HHS Regions/National,United States,2019,24 Months,70.1,68.7 to 71.5,17265
Combined 7 Series,,HHS Regions/National,United States,2019,35 Months,76,74.5 to 77.4,17265
DTaP,³1 Dose,HHS Regions/National,United States,2019,3 Months,90.9,90.1 to 91.7,17265
DTaP,³2 Doses,HHS Regions/National,United States,2019,5 Months,82.2,81.0 to 83.3,17265
DTaP,³3 Doses,HHS Regions/National,United States,2019,13 Months,90.9,90.0 to 91.7,17265
DTaP,³3 Doses,HHS Regions/National,United States,2019,19 Months,93.2,92.4 to 93.9,17265
DTaP,³3 Doses,HHS Regions/National,United States,2019,24 Months,94,93.2 to 94.6,17265
DTaP,³3 Doses,HHS Regions/National,United States,2019,35 Months,95.6,94.8 to 96.3,17265
DTaP,³3 Doses,HHS Regions/National,United States,2019,7 Months,72.6,71.2 to 73.9,17265
DTaP,³4 Doses,HHS Regions/National,United States,2019,19 Months,72.4,71.1 to 73.7,17265
DTaP,³4 Doses,HHS Regions/National,United States,2019,24 Months,81.2,80.0 to 82.4,17265
DTaP,³4 Doses,HHS Regions/National,United States,2019,35 Months,88.1,86.8 to 89.3,17265
Hep A,³1 Dose,HHS Regions/National,United States,2019,19 Months,84.5,83.4 to 85.5,17265
Hep A,³1 Dose,HHS Regions/National,United States,2019,24 Months,88.3,87.3 to 89.2,17265
Hep A,³1 Dose,HHS Regions/National,United States,2019,35 Months,92.6,91.6 to 93.6,17265
Hep A,³2 Doses,HHS Regions/National,United States,2019,19 Months,29.3,28.0 to 30.6,17265
Hep A,³2 Doses,HHS Regions/National,United States,2019,24 Months,47.9,46.4 to 49.5,17265
Hep A,³2 Doses,HHS Regions/National,United States,2019,35 Months,80.7,79.0 to 82.4,17265
Hep B,³1 Dose,HHS Regions/National,United States,2019,3 Months,96.4,95.8 to 96.9,17265
Hep B,"³1 Dose, 1 Day",HHS Regions/National,United States,2019,0-1 Days,77,75.7 to 78.2,17265
Hep B,"³1 Dose, 2 Day",HHS Regions/National,United States,2019,0-2 Days,80.5,79.3 to 81.6,17265
Hep B,"³1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2019,0-3 Days,81.5,80.4 to 82.6,17265
Hep B,³2 Doses,HHS Regions/National,United States,2019,13 Months,95.3,94.7 to 95.9,17265
Hep B,³2 Doses,HHS Regions/National,United States,2019,5 Months,90.4,89.5 to 91.2,17265
Hep B,³2 Doses,HHS Regions/National,United States,2019,7 Months,93.3,92.5 to 94.0,17265
Hep B,³3 Doses,HHS Regions/National,United States,2019,13 Months,89.2,88.3 to 90.1,17265
Hep B,³3 Doses,HHS Regions/National,United States,2019,19 Months,91.6,90.8 to 92.3,17265
Hep B,³3 Doses,HHS Regions/National,United States,2019,24 Months,92.6,91.8 to 93.3,17265
Hep B,³3 Doses,HHS Regions/National,United States,2019,35 Months,94.4,93.6 to 95.2,17265
Hep B,³3 Doses,HHS Regions/National,United States,2019,7 Months,62.5,61.0 to 63.9,17265
Hib,³1 Dose,HHS Regions/National,United States,2019,3 Months,88.8,87.8 to 89.7,17265
Hib,³2 Doses,HHS Regions/National,United States,2019,13 Months,94.6,94.0 to 95.2,17265
Hib,³2 Doses,HHS Regions/National,United States,2019,5 Months,80.2,79.0 to 81.4,17265
Hib,³2 Doses,HHS Regions/National,United States,2019,7 Months,91,90.1 to 91.8,17265
Hib,³3 Doses,HHS Regions/National,United States,2019,13 Months,75.4,74.2 to 76.6,17265
Hib,³3 Doses,HHS Regions/National,United States,2019,19 Months,90.5,89.7 to 91.3,17265
Hib,³3 Doses,HHS Regions/National,United States,2019,24 Months,92.6,91.8 to 93.3,17265
Hib,³3 Doses,HHS Regions/National,United States,2019,35 Months,93.9,93.1 to 94.6,17265
Hib,³3 Doses,HHS Regions/National,United States,2019,7 Months,56,54.5 to 57.4,17265
Hib,Full Series,HHS Regions/National,United States,2019,19 Months,74.7,73.4 to 75.9,17265
Hib,Full Series,HHS Regions/National,United States,2019,24 Months,79.9,78.7 to 81.1,17265
Hib,Full Series,HHS Regions/National,United States,2019,35 Months,84.5,83.2 to 85.7,17265
Hib,Primary Series,HHS Regions/National,United States,2019,13 Months,88.2,87.2 to 89.1,17265
Hib,Primary Series,HHS Regions/National,United States,2019,19 Months,93.1,92.3 to 93.7,17265
Hib,Primary Series,HHS Regions/National,United States,2019,24 Months,94,93.3 to 94.6,17265
Hib,Primary Series,HHS Regions/National,United States,2019,35 Months,94.9,94.2 to 95.5,17265
Hib,Primary Series,HHS Regions/National,United States,2019,7 Months,72.5,71.1 to 73.8,17265
Influenza,,HHS Regions/National,United States,2019,24 Months,63.8,62.3 to 65.2,17265
Influenza,,HHS Regions/National,United States,2019,35 Months,63.8,62.3 to 65.2,17265
MMR,³1 Dose,HHS Regions/National,United States,2019,13 Months,67.3,65.9 to 68.6,17265
MMR,³1 Dose,HHS Regions/National,United States,2019,19 Months,89.2,88.2 to 90.1,17265
MMR,³1 Dose,HHS Regions/National,United States,2019,24 Months,91.7,90.9 to 92.5,17265
MMR,³1 Dose,HHS Regions/National,United States,2019,35 Months,94.3,93.4 to 95.1,17265
PCV,³1 Dose,HHS Regions/National,United States,2019,3 Months,89.2,88.2 to 90.1,17265
PCV,³2 Doses,HHS Regions/National,United States,2019,5 Months,80.5,79.2 to 81.6,17265
PCV,³3 Doses,HHS Regions/National,United States,2019,13 Months,89.5,88.5 to 90.3,17265
PCV,³3 Doses,HHS Regions/National,United States,2019,19 Months,92.2,91.4 to 93.0,17265
PCV,³3 Doses,HHS Regions/National,United States,2019,24 Months,93.3,92.5 to 94.0,17265
PCV,³3 Doses,HHS Regions/National,United States,2019,35 Months,94.1,93.3 to 94.9,17265
PCV,³3 Doses,HHS Regions/National,United States,2019,7 Months,70,68.6 to 71.3,17265
PCV,³4 Doses,HHS Regions/National,United States,2019,19 Months,80.1,78.9 to 81.3,17265
PCV,³4 Doses,HHS Regions/National,United States,2019,24 Months,83.3,82.1 to 84.4,17265
PCV,³4 Doses,HHS Regions/National,United States,2019,35 Months,86.6,85.3 to 87.7,17265
Polio,³1 Dose,HHS Regions/National,United States,2019,3 Months,89.9,89.0 to 90.7,17265
Polio,³2 Doses,HHS Regions/National,United States,2019,13 Months,94.5,93.9 to 95.1,17265
Polio,³2 Doses,HHS Regions/National,United States,2019,5 Months,81.5,80.3 to 82.6,17265
Polio,³2 Doses,HHS Regions/National,United States,2019,7 Months,90.8,89.9 to 91.6,17265
Polio,³3 Doses,HHS Regions/National,United States,2019,19 Months,92,91.2 to 92.8,17265
Polio,³3 Doses,HHS Regions/National,United States,2019,24 Months,93,92.2 to 93.8,17265
Polio,³3 Doses,HHS Regions/National,United States,2019,35 Months,94.4,93.6 to 95.1,17265
Rotavirus,,HHS Regions/National,United States,2019,8 Months,76.8,75.5 to 78.0,17265
Varicella,³1 Dose,HHS Regions/National,United States,2019,13 Months,61.7,60.3 to 63.1,17265
Varicella,³1 Dose,HHS Regions/National,United States,2019,19 Months,88.5,87.5 to 89.4,17265
Varicella,³1 Dose,HHS Regions/National,United States,2019,24 Months,91.1,90.2 to 92.0,17265
Varicella,³1 Dose,HHS Regions/National,United States,2019,35 Months,94.6,93.5 to 95.5,17265
Combined 7 Series,,HHS Regions/National,United States,2020,24 Months,67.9,66.0 to 69.9,10468
Combined 7 Series,,HHS Regions/National,United States,2020,35 Months,73.9,71.7 to 76.2,10468
DTaP,³1 Dose,HHS Regions/National,United States,2020,3 Months,87.5,86.1 to 88.8,10468
DTaP,³2 Doses,HHS Regions/National,United States,2020,5 Months,79.9,78.2 to 81.5,10468
DTaP,³3 Doses,HHS Regions/National,United States,2020,13 Months,89.9,88.6 to 91.1,10468
DTaP,³3 Doses,HHS Regions/National,United States,2020,19 Months,92.7,91.6 to 93.6,10468
DTaP,³3 Doses,HHS Regions/National,United States,2020,24 Months,93.6,92.5 to 94.5,10468
DTaP,³3 Doses,HHS Regions/National,United States,2020,35 Months,94.5,93.2 to 95.7,10468
DTaP,³3 Doses,HHS Regions/National,United States,2020,7 Months,71.9,70.0 to 73.7,10468
DTaP,³4 Doses,HHS Regions/National,United States,2020,19 Months,70.6,68.7 to 72.4,10468
DTaP,³4 Doses,HHS Regions/National,United States,2020,24 Months,80.7,78.9 to 82.4,10468
DTaP,³4 Doses,HHS Regions/National,United States,2020,35 Months,87.7,85.6 to 89.6,10468
Hep A,³1 Dose,HHS Regions/National,United States,2020,19 Months,83.8,82.4 to 85.2,10468
Hep A,³1 Dose,HHS Regions/National,United States,2020,24 Months,88.5,87.2 to 89.7,10468
Hep A,³1 Dose,HHS Regions/National,United States,2020,35 Months,92.7,91.0 to 94.1,10468
Hep A,³2 Doses,HHS Regions/National,United States,2020,19 Months,29.6,28.0 to 31.4,10468
Hep A,³2 Doses,HHS Regions/National,United States,2020,24 Months,47.3,45.3 to 49.4,10468
Hep A,³2 Doses,HHS Regions/National,United States,2020,35 Months,77.3,73.9 to 80.4,10468
Hep B,³1 Dose,HHS Regions/National,United States,2020,3 Months,95.2,94.3 to 96.0,10468
Hep B,"³1 Dose, 1 Day",HHS Regions/National,United States,2020,0-1 Days,78,76.3 to 79.5,10468
Hep B,"³1 Dose, 2 Day",HHS Regions/National,United States,2020,0-2 Days,80.6,79.1 to 82.1,10468
Hep B,"³1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2020,0-3 Days,81.5,79.9 to 82.9,10468
Hep B,³2 Doses,HHS Regions/National,United States,2020,13 Months,93.8,92.8 to 94.7,10468
Hep B,³2 Doses,HHS Regions/National,United States,2020,5 Months,88.4,87.0 to 89.6,10468
Hep B,³2 Doses,HHS Regions/National,United States,2020,7 Months,91.6,90.4 to 92.7,10468
Hep B,³3 Doses,HHS Regions/National,United States,2020,13 Months,88.5,87.2 to 89.8,10468
Hep B,³3 Doses,HHS Regions/National,United States,2020,19 Months,90.7,89.5 to 91.8,10468
Hep B,³3 Doses,HHS Regions/National,United States,2020,24 Months,91.5,90.4 to 92.6,10468
Hep B,³3 Doses,HHS Regions/National,United States,2020,35 Months,92.9,91.4 to 94.2,10468
Hep B,³3 Doses,HHS Regions/National,United States,2020,7 Months,63.8,62.0 to 65.6,10468
Hib,³1 Dose,HHS Regions/National,United States,2020,3 Months,84.5,83.1 to 85.9,10468
Hib,³2 Doses,HHS Regions/National,United States,2020,13 Months,93,91.9 to 94.0,10468
Hib,³2 Doses,HHS Regions/National,United States,2020,5 Months,77.3,75.6 to 78.9,10468
Hib,³2 Doses,HHS Regions/National,United States,2020,7 Months,89,87.7 to 90.2,10468
Hib,³3 Doses,HHS Regions/National,United States,2020,13 Months,72.6,70.9 to 74.2,10468
Hib,³3 Doses,HHS Regions/National,United States,2020,19 Months,89.3,88.0 to 90.4,10468
Hib,³3 Doses,HHS Regions/National,United States,2020,24 Months,91.2,90.0 to 92.2,10468
Hib,³3 Doses,HHS Regions/National,United States,2020,35 Months,92.5,91.1 to 93.7,10468
Hib,³3 Doses,HHS Regions/National,United States,2020,7 Months,54.6,52.6 to 56.5,10468
Hib,Full Series,HHS Regions/National,United States,2020,19 Months,72.1,70.3 to 73.9,10468
Hib,Full Series,HHS Regions/National,United States,2020,24 Months,78.2,76.4 to 79.9,10468
Hib,Full Series,HHS Regions/National,United States,2020,35 Months,82.1,80.1 to 83.9,10468
Hib,Primary Series,HHS Regions/National,United States,2020,13 Months,86,84.5 to 87.3,10468
Hib,Primary Series,HHS Regions/National,United States,2020,19 Months,91.9,90.7 to 92.9,10468
Hib,Primary Series,HHS Regions/National,United States,2020,24 Months,92.7,91.7 to 93.7,10468
Hib,Primary Series,HHS Regions/National,United States,2020,35 Months,93.5,92.3 to 94.5,10468
Hib,Primary Series,HHS Regions/National,United States,2020,7 Months,72.7,70.9 to 74.4,10468
Influenza,,HHS Regions/National,United States,2020,24 Months,58.7,56.7 to 60.6,10468
Influenza,,HHS Regions/National,United States,2020,35 Months,58.7,56.7 to 60.6,10468
MMR,³1 Dose,HHS Regions/National,United States,2020,13 Months,66.9,64.9 to 68.7,10468
MMR,³1 Dose,HHS Regions/National,United States,2020,19 Months,88.3,87.0 to 89.5,10468
MMR,³1 Dose,HHS Regions/National,United States,2020,24 Months,91.4,90.3 to 92.5,10468
MMR,³1 Dose,HHS Regions/National,United States,2020,35 Months,93.4,92.1 to 94.5,10468
PCV,³1 Dose,HHS Regions/National,United States,2020,3 Months,86.1,84.6 to 87.4,10468
PCV,³2 Doses,HHS Regions/National,United States,2020,5 Months,78.4,76.7 to 80.0,10468
PCV,³3 Doses,HHS Regions/National,United States,2020,13 Months,88.6,87.1 to 89.9,10468
PCV,³3 Doses,HHS Regions/National,United States,2020,19 Months,91.6,90.4 to 92.7,10468
PCV,³3 Doses,HHS Regions/National,United States,2020,24 Months,92.4,91.2 to 93.4,10468
PCV,³3 Doses,HHS Regions/National,United States,2020,35 Months,93,91.8 to 94.1,10468
PCV,³3 Doses,HHS Regions/National,United States,2020,7 Months,69.4,67.5 to 71.3,10468
PCV,³4 Doses,HHS Regions/National,United States,2020,19 Months,77.5,75.7 to 79.2,10468
PCV,³4 Doses,HHS Regions/National,United States,2020,24 Months,82.1,80.4 to 83.8,10468
PCV,³4 Doses,HHS Regions/National,United States,2020,35 Months,84.6,82.7 to 86.3,10468
Polio,³1 Dose,HHS Regions/National,United States,2020,3 Months,87.5,86.1 to 88.7,10468
Polio,³2 Doses,HHS Regions/National,United States,2020,13 Months,93.5,92.5 to 94.3,10468
Polio,³2 Doses,HHS Regions/National,United States,2020,5 Months,79.6,78.0 to 81.2,10468
Polio,³2 Doses,HHS Regions/National,United States,2020,7 Months,89.9,88.7 to 91.0,10468
Polio,³3 Doses,HHS Regions/National,United States,2020,19 Months,91.8,90.7 to 92.8,10468
Polio,³3 Doses,HHS Regions/National,United States,2020,24 Months,92.9,91.9 to 93.9,10468
Polio,³3 Doses,HHS Regions/National,United States,2020,35 Months,94.4,93.0 to 95.7,10468
Rotavirus,,HHS Regions/National,United States,2020,8 Months,76.4,74.7 to 78.1,10468
Varicella,³1 Dose,HHS Regions/National,United States,2020,13 Months,61.7,59.8 to 63.6,10468
Varicella,³1 Dose,HHS Regions/National,United States,2020,19 Months,88.2,86.9 to 89.3,10468
Varicella,³1 Dose,HHS Regions/National,United States,2020,24 Months,91.2,90.1 to 92.3,10468
Varicella,³1 Dose,HHS Regions/National,United States,2020,35 Months,93.2,91.9 to 94.4,10468